Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports
Health Populi
MARCH 13, 2018
Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. The report pointed especially to hospital and pharmaceutical prices.
Let's personalize your content